monoethylglycinexylidide has been researched along with Chronic Illness in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Contos, MJ; Duckworth, PF; Edinboro, LE; Luketic, VA; Mills, AS; Poklis, A; Purdum, PP; Sanyal, AJ; Shiffman, ML | 1 |
| Deng, JF; Huang, YS; Lee, SD; Lin, YF; Lo, KJ; Lu, RH; Wang, YJ; Wu, JC | 1 |
| Armstrong, VW; Burdelski, M; Nolte-Buchholtz, S; Oellerich, M; Schütz, E | 1 |
| Luketic, VA; Sanyal, AJ; Shiffman, ML; Thompson, EB | 1 |
| DiBisceglie, AM; Elin, RJ; Fried, MW; Kleiner, DE; Ruddel, M; Sampson, M | 1 |
| Botta, F; Celle, G; Ceppa, P; Fasoli, A; Giannini, E; Lantieri, PB; Risso, D; Testa, R | 1 |
| Kupcová, V; Schmidtová, K; Szántová, M; Turecký, L | 1 |
| A-Kader, HH; Balistreri, WF; Gremse, DA; Schroeder, TJ | 1 |
1 trial(s) available for monoethylglycinexylidide and Chronic Illness
| Article | Year |
|---|---|
Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis.
Topics: Adult; Chronic Disease; Female; Follow-Up Studies; Galactose; Hepatitis; Humans; Indocyanine Green; Lidocaine; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prognosis; Prospective Studies; Prothrombin Time; Serum Albumin | 1993 |
7 other study(ies) available for monoethylglycinexylidide and Chronic Illness
| Article | Year |
|---|---|
Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis.
Topics: Adult; Aged; Alanine Transaminase; Chronic Disease; Female; Hepatitis; Humans; Lidocaine; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Sensitivity and Specificity | 1994 |
Prognostic value of the monoethylglycinexylidide test in pediatric liver transplant candidates.
Topics: Adolescent; Child; Child, Preschool; Chronic Disease; Female; Humans; Infant; Lidocaine; Liver Failure; Liver Function Tests; Liver Transplantation; Male; Prognosis; Prospective Studies; Sensitivity and Specificity; Survival Analysis | 1996 |
Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease.
Topics: Anesthetics, Local; Chronic Disease; Genetic Variation; Humans; Infusions, Intravenous; Lidocaine; Liver; Liver Cirrhosis; Liver Function Tests | 1996 |
Assessment of monoethylglycinexylidide as measure of liver function for patients with chronic viral hepatitis.
Topics: Adult; Biopsy; Chronic Disease; Female; Hepatitis, Viral, Human; Humans; Lidocaine; Liver; Liver Function Tests; Male; Middle Aged | 1997 |
Progressive liver functional impairment is associated with an increase in AST/ALT ratio.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Chronic Disease; Clinical Enzyme Tests; Disease Progression; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Lidocaine; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prognosis; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 1999 |
[Monoethylglycinexylidide--a metabolite of lidocaine--as an index of liver function in chronic hepatic parenchymal diseases].
Topics: Adult; Aged; Chronic Disease; Female; Fluorescence Polarization Immunoassay; Humans; Lidocaine; Liver Diseases; Liver Function Tests; Male; Middle Aged | 1999 |
Assessment of lidocaine metabolite formation as a quantitative liver function test in children.
Topics: Adolescent; Bilirubin; Child; Child, Preschool; Chronic Disease; Fluoroimmunoassay; Humans; Infant; Lidocaine; Liver Diseases; Liver Function Tests; Prognosis; Prothrombin Time; Serum Albumin | 1990 |